iBio, Inc. (IBIO:NASDAQ) closed at $0.732 on November 13, 2026, down 4.00% on the day. The stock trades 80.8% below its 52-week high of $3.82 and 6.0% above its 52-week low of $0.690. Over the past year, it lost 33.5%. iBio, Inc. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, IBIO closed higher on 102 days (40%). Its best day was December 8, 2025 (+39.17%) and its worst was March 26, 2026 (-20.18%). The stock moved 10% or more in a single session 19 times. It opened at least 5% above the previous day's high 5 times.
iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing and commercializing select biopharmaceutical product candidates. Its products are used to combat various areas such as fibrotic diseases, cancers, and infectious diseases. The company operates in two segments: biologics development and licensing activities, conducted within iBio, Inc.
Find more stocks like IBIO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.